Venture-Backed Startups

BioHeuris develops non-GMO herbicide tolerance traits for crops such as soybean, sorghum, cotton, and rice, using precision breeding and mutagenomic platforms to help crops resist weeds while reducing herbicide use. It works with seed and chemical companies to bring these traits to market through products like SURON, StrigOUT, and Raizor.

2 investors

0 investors

BioHive is a grassroots community organization that convenes Utah's life sciences and healthcare innovation industry, hosting events, education, and outreach to promote the ecosystem. It works to raise awareness, attract talent and investment, and connect founders, scientists, and companies across the state.

1 investor

BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.

3 investors

BIOHM develops microbiome-focused consumer health products, including probiotics and gut health tests, aimed at helping individuals understand and optimize their gut health. The company uses microbiome data and scientific research to inform its direct-to-consumer wellness products.

4 investors

0 investors

0 investors

Operates an online catalog of laboratory products, research reagents, and supplier references for professional research and laboratory purchasing workflows. Provides product information, supplier pages, and assistance for confirming product references.

1 investor

0 investors

0 investors

Biointaxis is an academic biotech spin-off developing a gene therapy to restore the function of a defective protein in patients with Friedreich's ataxia, a rare inherited neurodegenerative disease. The company handles early-stage R&D, pre-clinical, and early clinical (Phase I/II) development, aiming to license production and distribution rights to pharmaceutical partners.

1 investor

BioIntelligence Technologies builds an analytics platform that performs in-situ, simultaneous measurement of products, nutrients and metabolic intermediates with real-time analysis to optimize bioprocess profitability. It serves biotech companies in the transformation industry, targeting pharmaceutical and greener-chemical production.

2 investors

BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care. Founded in 2019, the company builds medical monitoring solutions for healthcare providers and patients.

4 investors

Tenzr Health provides a patient engagement and monitoring platform for physical and occupational therapy recovery. The platform enables care teams to track patient progress outside scheduled visits through guided exercises, education, and symptom tracking while capturing continuous recovery data.

1 investor

0 investors

BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.

3 investors

Bio Ionic sells hair styling tools such as blow-dryers, diffusers, and stylers built around an ionic "Moisturizing Heat" technology intended to dry and style hair faster while keeping it hydrated. It is a consumer hair care and beauty appliance brand sold directly to shoppers.

1 investor

Provides an at-home healthcare platform (operating under LetsGetChecked) with vertically integrated labs, manufacturing, telehealth, and patient engagement to deliver screening and testing programs such as biometrics, cancer, genomics, and infectious disease testing. Serves employers, health plans, providers, and public sector organizations to close gaps in care and expand healthcare access.

1 investor

An online store selling human growth hormone (HGH) injections, peptides, and related products such as Zptropin, Genotropin, Somatropin, Semaglutide, and Ozempic, marketed for bodybuilding, fat loss, and anti-aging. The site targets consumers seeking to buy these products at low prices, claiming US domestic fulfillment.

1 investor

Biokangtai develops and manufactures human vaccines, including a 13-valent pneumococcal polysaccharide conjugate vaccine, a four-dose freeze-dried human rabies vaccine (human diploid cell), a combined acellular DTP–Hib vaccine, and a 60µg hepatitis B vaccine.

1 investor

BioKier develops oral products for managing lipids and glucose in type 2 diabetes and cardiometabolic disorders, designed to replicate the metabolic benefits of bariatric surgery through colon-targeted nutrient delivery. The company is a clinical-stage biotech pursuing regulatory approval via the 505(b)2 NDA pathway.

1 investor

Biokine Therapeutics is a private biopharmaceutical company developing cancer therapeutics targeting tumor migration, survival, and immune-response pathways; its lead product BKT140/BL8040 is a CXCR4 receptor inhibitor used for stem cell mobilization and cancer immunotherapy. The company has also built the MigHit and ImmunHit phenotypic screening platforms to identify small molecules targeting migration/survival pathways and IFN-g mediated immune responses in cancer and inflammation.

1 investor

Biokorf works on 3D Integrated Pharmaceuticals, including particle engineering and cocrystals for drug development.

1 investor

BioLamina develops full-length human recombinant laminin products (Biolaminin) that provide cell-type-specific substrates for 2D and 3D cell culture, supporting stem cell research and clinical cell therapy development. Its animal-origin-free, regulatory-compliant products serve researchers and cell therapy developers working on experimental standardization and clinical applications.

1 investor